Contract 36F79723D0039
Accord Biopharma, Inc. · Department Of Veterans Affairs · December 6, 2022
Accord Biopharma, Inc. was awarded a federal contract by Department Of Veterans Affairs on December 6, 2022 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 16 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on April 6, 2026. If all options are exercised, the contract could reach $300,000.
Contract details
- PIID
- 36F79723D0039
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- December 6, 2022
- Latest action
- April 6, 2026
Description
42-2A DELETION 3 NDCS
Modification timeline
-
April 6, 2026Mod P00022$0
-
March 27, 2026Mod P00019ADMINISTRATIVE CHANGE$0
-
January 26, 2026Mod P00017PRODUCT LIFE CYCLE$0
-
January 22, 2026Mod P00012NDC CHANGE$0
-
January 22, 2026Mod P00014NDC CHANGE$0
-
January 14, 2026Mod P00015TEMPORARY PRICE REDUCTION$0
-
December 13, 2025Mod P000132026 PUBLIC LAW UPDATE$0
-
November 13, 2025Mod P00011PRODUCT LIFE CYCLE$0
-
October 1, 2025Mod P00010PRODUCT ADDITION$0
-
September 29, 2025Mod P00009TEMPORARY PRICE REDUCTION$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79723D0039?
Contract 36F79723D0039 is a federal contract awarded to Accord Biopharma, Inc. by Department Of Veterans Affairs on December 6, 2022 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 16 times since the base award.
Who won contract 36F79723D0039?
Accord Biopharma, Inc. won contract 36F79723D0039 from Department Of Veterans Affairs.
How much is contract 36F79723D0039 worth?
Contract 36F79723D0039 has obligated $0 to date but carries a potential ceiling of $300,000 if fully funded and all options are exercised.